Login
Discover
Waves
Decks
Plus
Login
Signup
Topics
New
Trending
Hot
New
New
Trending
Hot
New
Payouts
Muted
Promoted
Global
Top communities
Create your community
latest #theragenomics created topics on internet
gut50
theragenomics
2019-05-16 14:49
Febuxostat (Uloric) and its problem with cardiovascular mortality
Despite drug safety problems of cardiovascular mortality with Febuxostat (Uloric), the benefits might still be seen to outweigh risks for selected gout patients. This notion may become more and more disputed,
$ 0.000
1
2
gut50
theragenomics
2019-05-04 07:15
Grossesse et risques de malformations: Il n'y a pas seulement le valproate
may 01, 2019 - En France, l’Agence nationale de sécurité du médicament et des produits de santé (ANSM) viens de publier une analyse des données disponibles sur le risque de malformations et de troubles
$ 0.000
4
1
gut50
theragenomics
2019-05-02 04:55
Lemtrada: Deleterious unwanted effects in some multiple sclerosis patients
Lemtrada: Deleterious unwanted effects in some multiple sclerosis patients Alemtuzumab (Lemtrada) is used in the treatment of multiple sclerosis (MS). Moreover, Alemtuzumab, under the Tradenames of Campt,
$ 0.000
4
